⌘K

Home/Filings/4/0001574774-18-000056

4//SEC Filing

Broadway Fred 4

Accession 0001574774-18-000056

CIK 0001574774other

View on SEC.gov Company Profile

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:23 PM ET

Size

15.1 KB

Accession

0001574774-18-000056

Insider Transaction Report

Form 4

Period: 2018-09-28

BIOTELEMETRY, INC.BEAT

SVP - Sales Marketing

Transactions

Exercise/Conversion
Common Stock
2018-09-28$2.54/sh+23,912$60,736→ 114,993 total
Exercise/Conversion
Stock Options (Right to Buy)
2018-09-28−26,963→ 0 total
Exercise: $2.80Exp: 2022-02-21→ Common Stock (26,963 underlying)
Exercise/Conversion
Common Stock
2018-09-28$4.67/sh+39,238$183,241→ 64,118 total
Exercise/Conversion
Common Stock
2018-09-28$2.80/sh+26,963$75,496→ 91,081 total
Sale
Common Stock
2018-09-28$65.00/sh−90,113$5,857,345→ 24,880 total
Exercise/Conversion
Stock Options (Right to Buy)
2018-09-28−39,238→ 0 total
Exercise: $4.67Exp: 2021-03-04→ Common Stock (39,238 underlying)
Exercise/Conversion
Stock Options (Right to Buy)
2018-09-28−23,912→ 0 total
Exercise: $2.54Exp: 2023-02-19→ Common Stock (23,912 underlying)

Footnotes (4)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018.
[F2]The options were fully exercisable on December 31, 2014.
[F3]The options were fully exercisable on December 31, 2015.
[F4]The options were fully exercisable on February 19, 2017.

Documents

1 file

4
wf-form4_153851182097048.xmlPrimary
FORM 4

Issuer

BIOTELEMETRY, INC.

CIK 0001574774

Entity typeother

Related Parties

1

filerCIK 0001557180

Filing Metadata

Form type: 4
Filed: Oct 1, 8:00 PM ET
Accepted: Oct 2, 4:23 PM ET
Size: 15.1 KB

View on SEC.gov